Fibrogen Inc (FGEN)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
06-Dec-19 7:51 PM
View: 
Yu K Peony
Chief Medical Officer
Fibrogen Inc (FGEN) 06-Dec-19Payment of Exercise 3,360$47.39$159,230.00(2%)
179.4K to 176.04K
06-Dec-19 7:51 PM
View: 
Yu K Peony
Chief Medical Officer
Fibrogen Inc (FGEN) 04-Dec-19Option Exercise 4,157$17.46$72,575.802%
175.24K to 179.4K
15-Nov-19 6:07 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 14-Nov-19Option Exercise 5,625$21.84$122,838.004%
139.63K to 145.25K
15-Nov-19 6:07 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 14-Nov-19Planned Option Sale 5,625$34.74$195,440.00(4%)
145.25K to 139.63K
15-Nov-19 6:07 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 13-Nov-19Planned Option Sale 5,625$34.54$194,288.00(4%)
145.25K to 139.63K
15-Nov-19 6:07 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 13-Nov-19Option Exercise 5,625$19.39$109,069.004%
139.63K to 145.25K
12-Nov-19 9:15 PM
View: 
Controneo Pat
SVP, Finance and CFO
Fibrogen Inc (FGEN) 08-Nov-19Option Exercise 12,500$2.90$36,250.005%
244.43K to 256.93K
08-Nov-19 6:05 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 07-Nov-19Option Exercise 6,000$9.77$58,650.0021%
28.4K to 34.4K
08-Nov-19 6:05 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 07-Nov-19Market Option Sale (Planned) 6,000$38.27$229,624.00(17%)
34.4K to 28.4K
10-Oct-19 7:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 09-Oct-19Market Option Sale (Planned) 5,625$36.58$205,763.00(4%)
145.25K to 139.63K
10-Oct-19 7:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 09-Oct-19Option Exercise 5,625$19.39$109,069.004%
139.63K to 145.25K
10-Oct-19 7:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 08-Oct-19Market Option Sale (Planned) 5,625$36.78$206,914.00(4%)
145.25K to 139.63K
10-Oct-19 7:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 08-Oct-19Option Exercise 5,625$19.39$109,069.004%
139.63K to 145.25K
09-Oct-19 8:26 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 07-Oct-19Option Exercise 6,000$9.77$58,650.0021%
28.4K to 34.4K
09-Oct-19 8:26 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 07-Oct-19Market Option Sale (Planned) 6,000$36.73$220,380.00(17%)
34.4K to 28.4K
23-Sep-19 6:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 20-Sep-19Market Option Sale (Planned) 2,120$39.87$84,524.40(1%)
145.25K to 143.13K
23-Sep-19 6:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 20-Sep-19Market Sale (Planned) 3,505$39.87$139,744.00(2%)
143.13K to 139.63K
23-Sep-19 6:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 20-Sep-19Option Exercise 5,625$19.39$109,069.004%
139.63K to 145.25K
23-Sep-19 6:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 19-Sep-19Market Option Sale (Planned) 5,625$40.45$227,550.00(4%)
145.25K to 139.63K
23-Sep-19 6:57 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 19-Sep-19Option Exercise 2,120$19.39$41,106.801%
143.13K to 145.25K
20-Sep-19 6:00 PM
View: 
Schoeneck James A
Interim CEO
Director
Fibrogen Inc (FGEN) 18-Sep-19Grant 57,300----123%
46.4K to 103.7K
18-Sep-19 7:42 PM
View: 
Controneo Pat
SVP, Finance and CFO
Fibrogen Inc (FGEN) 17-Sep-19Market Sale (Planned) 3,201$41.38$132,457.00(1%)
247.63K to 244.43K
< 1%
18-Sep-19 7:45 PM
View: 
Yu K Peony
Chief Medical Officer
Fibrogen Inc (FGEN) 16-Sep-19Market Sale (Planned) 3,419$40.92$139,905.00(2%)
178.66K to 175.24K
(1%)
10-Sep-19 8:29 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 09-Sep-19Market Option Sale (Planned) 6,000$40.95$245,723.00(17%)
34.4K to 28.4K
10-Sep-19 8:29 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 09-Sep-19Option Exercise 6,000$5.95$35,700.0021%
28.4K to 34.4K
10-Sep-19 8:28 PM
View: 
Controneo Pat
SVP, Finance and CFO
Fibrogen Inc (FGEN) 06-Sep-19Payment of Exercise 3,144$41.68$131,042.00(1%)
250.78K to 247.63K
< 1%
10-Sep-19 8:26 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 06-Sep-19Payment of Exercise 8,437$41.68$351,654.00(6%)
151.57K to 143.13K
< 1%
10-Sep-19 8:33 PM
View: 
Yu K Peony
Chief Medical Officer
Fibrogen Inc (FGEN) 06-Sep-19Payment of Exercise 8,317$41.68$346,653.00(4%)
186.98K to 178.66K
< 1%
10-Sep-19 8:31 PM
View: 
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Fibrogen Inc (FGEN) 06-Sep-19Payment of Exercise 5,541$41.68$230,949.00(5%)
109.2K to 103.66K
< 1%
26-Aug-19 7:33 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 23-Aug-19Option Exercise 5,625$19.39$109,069.004%
151.57K to 157.19K
26-Aug-19 7:33 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 23-Aug-19Market Option Sale (Planned) 5,625$42.51$239,099.00(4%)
157.19K to 151.57K
26-Aug-19 7:33 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 22-Aug-19Option Exercise 5,625$19.39$109,069.004%
151.57K to 157.19K
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 22-Aug-19Option Exercise 6,834$2.90$19,818.60< 1%
2.46M to 2.47M
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 22-Aug-19Private Sale (Planned) 12,984$43.87$569,552.00(< 1%)
2.47M to 2.45M
26-Aug-19 7:33 PM
View: 
Chung Christine
SVP, China Operations
Fibrogen Inc (FGEN) 22-Aug-19Planned Private Option Sale 5,625$43.84$246,583.00(4%)
157.19K to 151.57K
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 22-Aug-19Private Sale (Planned) 1,418$43.77$62,065.90(< 1%)
2.45M to 2.45M
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 22-Aug-19Planned Private Option Sale 5,416$43.87$237,577.00(< 1%)
2.47M to 2.47M
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 21-Aug-19Private Sale (Planned) 11,566$44.79$518,041.00(< 1%)
2.48M to 2.47M
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 21-Aug-19Planned Private Option Sale 1,418$44.81$63,540.60(< 1%)
2.47M to 2.46M
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 21-Aug-19Option Exercise 6,834$2.90$19,818.60< 1%
2.48M to 2.48M
23-Aug-19 4:49 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 21-Aug-19Planned Private Option Sale 6,834$44.79$306,095.00(< 1%)
2.48M to 2.48M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 13-Aug-19Private Sale (Planned) 12,984$45.65$592,752.00(< 1%)
2.49M to 2.48M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 13-Aug-19Option Exercise 6,834$2.90$19,818.60< 1%
2.49M to 2.5M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 13-Aug-19Private Sale (Planned) 1,418$45.61$64,679.60(< 1%)
2.48M to 2.48M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 13-Aug-19Planned Private Option Sale 5,416$45.65$247,254.00(< 1%)
2.5M to 2.49M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 12-Aug-19Private Sale (Planned) 11,566$45.24$523,191.00(< 1%)
2.5M to 2.49M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 12-Aug-19Option Exercise 6,834$2.90$19,818.60< 1%
2.5M to 2.51M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 12-Aug-19Planned Private Option Sale 1,418$45.17$64,055.70(< 1%)
2.49M to 2.49M
14-Aug-19 10:00 PM
View: 
Neff Thomas B
Chief Executive Officer
Director
Fibrogen Inc (FGEN) 12-Aug-19Planned Private Option Sale 6,834$45.24$309,138.00(< 1%)
2.51M to 2.5M
07-Aug-19 4:42 PM
View: 
Kurkijarvi Kalevi
Director
Fibrogen Inc (FGEN) 05-Aug-19Option Exercise 6,000$3.50$21,000.0021%
28.4K to 34.4K